Collaborating Against Cancer

Taking Cancer On

English - June 04, 2021 16:05 - 29 minutes - 24.1 MB - ★★★★ - 2 ratings
Medicine Health & Fitness Science Life Sciences cancer cancer research oncology oncology research taking cancer on drug discovery drug development treatment development clinical trials drug approval Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Under the Surface of Clinical Trials

Next Episode: Helping the Immune System to Take Cancer On

In this episode, we hear from Dr Scott DeWire, Head of US Business Development at Boehringer Ingelheim (BI) and Dr Andrew Fadden, Head of Corporate Development at Enara Bio about the power of research partnerships in progressing cancer innovation and drug development. Their discussion proves that embracing collaboration is essential in delivering ground-breaking treatments to patients, faster. What do pharmaceutical partnerships entail? What can we gain from collaborating with partners? Do we share the same goals? Listen to this episode to find out more!

Research Partnerships

Hosted by Sebastian Hermelin and featuring guests Dr Scott DeWire and Dr Andrew Fadden.

In this episode we cover:
[4:16] Boehringer Ingelheim & Enara Bio partnership
[14:57] Importance of patients in pharmaceutical partnerships
[21:14] Pharmaceutical partnerships in general
[24:43] Boehringer Ingelheim & Enara Bio's partnering philosophy